# Synbiotic Therapy on Intestinal Microbiota and Insulin Resistance in Obesity

> **NCT04642482** · PHASE4 · COMPLETED · sponsor: **Hasanuddin University** · enrollment: 16 (actual)

## Conditions studied

- Obesity
- Insulin Resistance

## Interventions

- **DIETARY_SUPPLEMENT:** Synbiotic (Rillus)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04642482
- **Lead sponsor:** Hasanuddin University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-24
- **Primary completion:** 2019-12-26
- **Final completion:** 2020-09-01
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2020-11-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04642482

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04642482, "Synbiotic Therapy on Intestinal Microbiota and Insulin Resistance in Obesity". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04642482. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*